Integrated BioPharma (INBP) Stock Analysis & Winston Score
Integrated BioPharma is a company that makes nutritional supplements and vitamins. Its products include vitamins, minerals, herbal supplements, and sports nutrition items sold under several brand names. The company sells to retailers, health food stores, and consumers, placing it in the broader packaged health and wellness industry. The company earns money by manufacturing and selling these supplement products, operating primarily in the United States. With a market cap near zero and negative operating margins, the business has faced serious financial difficulties, including past bankruptcy proceedings. The core risk here is the company's weak financial position — razor-thin gross margins of around 5% leave almost no room for error, and the business has struggled to generate consistent profits in a crowded supplement market where larger, better-funded competitors have significant advantages in distribution and brand recognition.
Winston Score: 20/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (1/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.16
Market Cap: $5M
Sector: Healthcare
Industry: Medical - Pharmaceuticals


